JP2021514384A5 - - Google Patents

Info

Publication number
JP2021514384A5
JP2021514384A5 JP2020565533A JP2020565533A JP2021514384A5 JP 2021514384 A5 JP2021514384 A5 JP 2021514384A5 JP 2020565533 A JP2020565533 A JP 2020565533A JP 2020565533 A JP2020565533 A JP 2020565533A JP 2021514384 A5 JP2021514384 A5 JP 2021514384A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
group
alkyloxy
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020565533A
Other languages
English (en)
Japanese (ja)
Other versions
JP7399109B2 (ja
JP2021514384A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/053074 external-priority patent/WO2019154950A1/en
Publication of JP2021514384A publication Critical patent/JP2021514384A/ja
Publication of JP2021514384A5 publication Critical patent/JP2021514384A5/ja
Application granted granted Critical
Publication of JP7399109B2 publication Critical patent/JP7399109B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020565533A 2018-02-08 2019-02-08 縮合チオフェン誘導体及びそれらの使用 Active JP7399109B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18305133.3 2018-02-08
EP18305133 2018-02-08
PCT/EP2019/053074 WO2019154950A1 (en) 2018-02-08 2019-02-08 Fused thiophene derivatives and their uses

Publications (3)

Publication Number Publication Date
JP2021514384A JP2021514384A (ja) 2021-06-10
JP2021514384A5 true JP2021514384A5 (cg-RX-API-DMAC7.html) 2022-02-15
JP7399109B2 JP7399109B2 (ja) 2023-12-15

Family

ID=61283123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020565533A Active JP7399109B2 (ja) 2018-02-08 2019-02-08 縮合チオフェン誘導体及びそれらの使用

Country Status (12)

Country Link
US (2) US11492347B2 (cg-RX-API-DMAC7.html)
EP (2) EP3749658A1 (cg-RX-API-DMAC7.html)
JP (1) JP7399109B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200141436A (cg-RX-API-DMAC7.html)
CN (1) CN111954668A (cg-RX-API-DMAC7.html)
AU (1) AU2019216793B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020015907A2 (cg-RX-API-DMAC7.html)
CA (1) CA3087829A1 (cg-RX-API-DMAC7.html)
EA (1) EA202091889A1 (cg-RX-API-DMAC7.html)
IL (1) IL275905A (cg-RX-API-DMAC7.html)
MX (1) MX2020007918A (cg-RX-API-DMAC7.html)
WO (2) WO2019154949A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102218333B1 (ko) 2016-06-07 2021-02-22 자코바이오 파마슈티칼스 컴퍼니 리미티드 Shp2 억제제로서 유용한 신규한 헤테로환형 유도체
SG11201908820VA (en) 2017-03-23 2019-10-30 Jacobio Pharmaceuticals Co Ltd Novel heterocyclic derivatives useful as shp2 inhibitors
MX2020007918A (es) 2018-02-08 2020-12-03 Enyo Pharma Derivados fusionados de tiofeno y sus usos.
EA202091897A1 (ru) 2018-02-08 2020-10-27 Энио Фарма Неконденсированные производные тиофена и их применение
CN112839935A (zh) 2018-09-26 2021-05-25 北京加科思新药研发有限公司 可用作shp2抑制剂的新型杂环衍生物
WO2020210582A1 (en) * 2019-04-11 2020-10-15 University Of The Sciences Allosteric agonists and positive allosteric modulators of glucagon-like peptide 1 receptor
RU2756587C9 (ru) * 2021-02-12 2021-10-12 Акционерное общество "Отисифарм" Производные 2-ацетамидо-6-гидрокси-бензотиофена и их фармацевтически приемлемые соли, обладающие противовирусной активностью
JP7849841B2 (ja) 2021-02-16 2026-04-22 ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド リソソーム関連膜タンパク質標的化化合物及びその使用
TWI815475B (zh) * 2021-05-27 2023-09-11 財團法人國家衛生研究院 Cdgsh鐵硫結構域2活化劑及其用途
CN113264917B (zh) * 2021-05-28 2022-07-01 华南理工大学 一种抗乙肝病毒化合物及其制备方法和应用
CN113501807A (zh) * 2021-06-10 2021-10-15 重庆科技学院 四氢苯并噻吩类化合物及药物组合物的制备方法和用途
WO2023114761A2 (en) * 2021-12-14 2023-06-22 West Virginia University Board of Governors on behalf of West Virginia University Targeting ero1 alpha with aurone derivatives
CN114891013A (zh) * 2022-05-06 2022-08-12 南方科技大学 三尖杉碱类化合物的衍生物及其制备方法、药物组合物和用途
CN117004526A (zh) * 2023-08-04 2023-11-07 浙江工业大学 奥巴涅斯分枝杆菌wml及其在降解有机污染物中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6339198A (en) * 1997-02-26 1998-09-18 Ciblex Corporation Inhibitors of leaderless protein export
US20040171603A1 (en) 2001-05-18 2004-09-02 Janos Pato Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
EP1670804A2 (en) 2003-09-10 2006-06-21 GPC Biotech AG Heterobicyclic compounds as pharmaceutically active agents
WO2006093518A2 (en) 2004-06-25 2006-09-08 Apath, Llc Thienyl compounds for treating virus-related conditions
EP1802634A2 (en) 2004-10-20 2007-07-04 Compass Pharmaceuticals LLC Thiophens and their use as anti-tumor agents
WO2009026172A2 (en) 2007-08-17 2009-02-26 The Regents Of The University Of California New approach for designing diabetes drugs
US20110015239A1 (en) 2007-12-14 2011-01-20 The Regents Of The University Of California Inhibitors of calcium-activated chloride channels
US20110319416A1 (en) 2009-01-28 2011-12-29 Emory University Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions
WO2011097607A1 (en) * 2010-02-08 2011-08-11 Southern Research Institute Anti-viral treatment and assay to screen for anti-viral agent
US8765803B1 (en) 2011-03-02 2014-07-01 Stc.Unm Rab7 GTPase inhibitors and related methods of treatment
WO2012148889A1 (en) 2011-04-28 2012-11-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inhibitors of human apurinic/apyrimidinic endonuclease 1
KR20150046259A (ko) 2012-08-23 2015-04-29 앨리오스 바이오파마 인크. 파라믹소바이러스 바이러스성 감염의 치료용 화합물
JP2014169257A (ja) 2013-03-05 2014-09-18 Kyowa Hakko Kirin Co Ltd 縮環チオフェン誘導体
US10647725B2 (en) 2016-04-21 2020-05-12 The University Of Toledo Anti-infective 2-aminothiophenes
KR20190098204A (ko) 2016-12-29 2019-08-21 엔요 파마 항바이러스제로서의 티오펜 유도체
EA202091897A1 (ru) 2018-02-08 2020-10-27 Энио Фарма Неконденсированные производные тиофена и их применение
MX2020007918A (es) 2018-02-08 2020-12-03 Enyo Pharma Derivados fusionados de tiofeno y sus usos.
EP3749292A1 (en) 2018-02-08 2020-12-16 ENYO Pharma Use of modulators of neet proteins for the treatment of infection

Similar Documents

Publication Publication Date Title
JP2021514385A5 (cg-RX-API-DMAC7.html)
JP2022544714A5 (cg-RX-API-DMAC7.html)
JP2024050527A5 (cg-RX-API-DMAC7.html)
JP2023534983A5 (cg-RX-API-DMAC7.html)
JP2022501430A5 (cg-RX-API-DMAC7.html)
JP2023539584A5 (cg-RX-API-DMAC7.html)
WO2022230912A1 (ja) 置換トリアジン化合物
JP2024512154A5 (cg-RX-API-DMAC7.html)
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
JP2011528370A5 (cg-RX-API-DMAC7.html)
JP2022505525A5 (cg-RX-API-DMAC7.html)
RU2011105422A (ru) Дейтерированные бензилбензольные производные и способы применения
IL275893B2 (en) The history of unfused thiophene and their uses
JP2024513227A5 (cg-RX-API-DMAC7.html)
RU2019100164A (ru) Гетероциклическое соединение, используемое как ингибитор fgfr
JP2018534288A5 (cg-RX-API-DMAC7.html)
JP2009515992A5 (cg-RX-API-DMAC7.html)
JP2017514856A5 (cg-RX-API-DMAC7.html)
JP2021512114A5 (cg-RX-API-DMAC7.html)
RU2017110211A (ru) ИНГИБИТОРЫ α-АМИНО-β-КАРБОКСИМУКОНАТ-ε-СЕМИАЛЬДЕГИД-ДЕКАРБОКСИЛАЗЫ
JP2019502659A5 (cg-RX-API-DMAC7.html)
RU2010144744A (ru) Композиции и способы иммунотерапии
JP2023504541A5 (cg-RX-API-DMAC7.html)
JP2022543666A5 (cg-RX-API-DMAC7.html)
JP2013542267A5 (cg-RX-API-DMAC7.html)